Related Experiment Video
Updated: Apr 22, 2026

06:54
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
10.8K
Fluorogenic Heterodimers Enable Rapid Fluorescence Lifetime Imaging of Prostate-Specific Membrane Antigen-Positive
Zhuang Shao1, Xuejiao Chen1, Hongchuang Xu2
1Department of Nuclear Medicine, Peking University People's Hospital, Beijing 100044, China.
ACS Sensors
|April 21, 2026
Summary
This study introduces a new method for prostate cancer surgery using activatable near-infrared (NIR) probes that rapidly illuminate cancer cells. This approach enhances surgical precision and reduces tumor recurrence by improving visualization during operations.
Area of Science:
- Biomedical Engineering
- Organic Chemistry
- Oncology
Background:
- Accurate prostate cancer margin delineation is critical to prevent recurrence.
- Current fluorescence-guided surgery (FGS) probes have limitations like high background noise or slow activation.
- Prostate-specific membrane antigen (PSMA) is a target for FGS in prostate cancer.
Purpose of the Study:
- To develop a novel strategy for rapidly activatable NIR probes for PSMA-targeted FGS.
- To create probes with enhanced fluorescence properties and fast activation kinetics.
- To evaluate the efficacy of these probes in real-time imaging for prostate cancer surgery.
Main Methods:
- Developed a modular design using fluorogenic heterodimers for rapid NIR fluorescence activation.
- Synthesized and optimized environment-sensitive cyanine-based fluorophores (e.g., Cy1a).
- Conjugated a PSMA-targeting ligand to create the activatable probe Cy2a.
Main Results:
- The optimal fluorophore Cy1a showed a 120-fold fluorescence enhancement.
- Cy2a demonstrated rapid, PSMA-binding-dependent fluorescence activation and extended fluorescence lifetime (0.16 to 1.01 ns).
- Cy2a enabled real-time, PSMA-specific imaging in live cells and achieved high tumor-to-background contrast in tissues and animal models.
Conclusions:
- Established a versatile strategy for creating fast-activatable NIR probes.
- Demonstrated Cy2a's potential for precise, real-time imaging in prostate cancer surgery.
- The fluorescence lifetime-based analysis offers spatial resolution of probe-target interactions.

